His Mind Helped Rebuild New York. His Body Is Failing Him.
Reposted from the NYTimes.comBy Christopher MaagPublished Sept. 6, 2023 Dan Doctoroff once had more power to decide what got built…
Packard Center’s 23rd Annual Symposium brings together established luminaries in ALS research and rising stars from around the world.
Hundreds of people in the ALS community gathered in person and online for the 23rd Annual Packard Center…
AFTD/Packard Center Scientific Meeting Highlights New Collaborations, New Approaches
ALS and FTD are complex diseases, with many steps in the disease pathways still unknown. But the two…
Tara Lincoln joins Packard Center team as new Director, Operations and Administration
2023 has been a big year of change for the Packard Center. Besides a new Scientific Director, Packard…
Christine Vande Velde Joins Packard Center team as new Science Director
Earlier this year, the Packard Center welcomed its new Scientific Director, Dr. Christine Vande Velde. Dr. Vande Velde…
FDA grants accelerated approval of tofersen for treatment of SOD1-ALS
The Food and Drug Administration granted accelerated approval of the drug tofersen for the treatment of SOD1-ALS. Developed by…
Research Byte: Packard researchers identify new function of C9 protein
In a new paper in PLOS Genetics, Packard researcher Jiou Wang identified a new mechanism through which C9orf72…
Answer ALS is proud to announce the public release of new in-depth biological and clinical datasets to aid ALS research
A new set of Answer ALS project data is now available through the Answer ALS Data Portal. A…
New links between toxic protein and ALS discovered
Neuroscientists at Thomas Jefferson University have identified a new way that repeat expansion in the C9orf72 gene—the most…
New Phase 2 trial results show promise for ALS
Results of a new Phase 2 randomized clinical trial in 137 patients with ALS showed that treatment with…